Riccardo Dolcetti,Massimo Guidoboni,Valli De Re,Daniela Gasparotto,Sonia Castiglioni,Maria Luisa Nolli
申请号:
US12670949
公开号:
US08512703B2
申请日:
2008.07.24
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations.